Markus Zeeb

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Boehringer Ingelheim (Austria)17.5%
• University of Toronto8.1%
• Frederick National Laboratory for Cancer Research7.9%
• Structural Genomics Consortium7.4%
• AstraZeneca (United Kingdom)6.7%
• University of Oxford6.7%
• Other45.6%

Fields

• Biochemistry, Genetics and Molecular Biology68.1%
• Medicine15.5%
• Computer Science7.8%
• Immunology and Microbiology3.2%
• Chemistry3%
• Agricultural and Biological Sciences0.8%
• Other1.6%

Topics

• Protein Degradation and Inhibitors18.4%
• Protein Kinase Regulation and GTPase Signaling11.5%
• Ubiquitin and proteasome pathways8.4%
• Computational Drug Discovery Methods7.9%
• Protein Structure and Dynamics6.4%
• Peptidase Inhibition and Analysis6%
• Other41.5%